Treatment of Sequelae Caused by Severe Brain Injury With Autologous Adipose-derived Mesenchymal Stem Cells
Treatment of Sequelae Caused by Severe Brain Injury With Autologous Adipose-derived Mesenchymal Stem Cells
The study is to investigate the efficacy and safety of autologous transplantation of
 adipose-derived mesenchymal stem cells in patients with the sequelae caused by severe brain
 injury.
Inclusion Criteria:

 -  Subject has a confirmed diagnosis of a brain AVM (arteriovenous malformation).

 -  Stroke-like symptoms, including paralysis, caused by brain AVM hemorrhage.

 -  Subject's modified Rankin scale (mRS) grades IV~V.

 -  Ages between 20~40 years.

 -  Estimated life expectancy must be greater than 2 months.

 -  Signed informed consent from the subject.

 Exclusion Criteria:

 -  Pregnancy test positive.

 -  Subject infected with hepatitis C, HIV or syphilis.

 -  Subject not suitable for liposuction surgery.

 -  Subject not eligible for PET or MRI.

 -  Subject enrolled in any other cell therapy studies within the past 30 days.

 -  Subject deemed to be not suitable for the study by the investigator.